Hladik F - Search Results

1

Studies on the mechanism of tolerance or graft-versus-host disease in allogeneic bone marrow recipients at the level of cytotoxic T-cell precursor frequencies.

Irschick EU, Hladik F, Niederwieser D, Nussbaumer W, Holler E, Kaminski E, Huber C. Irschick EU, et al. Among authors: hladik f. Blood. 1992 Mar 15;79(6):1622-8. Blood. 1992. PMID: 1547351 Free article.

2

Clonal reduction of CTL-P and acquired allograft tolerance in various human transplantation models.

Irschick E, Hladik F, Berger M, Niederwieser D, Herzog W, Zanker B, Kabelitz D, Margreiter K, Auböck J, Miller K, et al. Irschick E, et al. Among authors: hladik f. Transplant Proc. 1990 Aug;22(4):1869-70. Transplant Proc. 1990. PMID: 2389464 No abstract available.

3

IL-2, IL-3, and IFN-gamma differently affect in vivo frequencies of circulating precursors of cytotoxic T lymphocytes (CTL-P).

Hladik F, Kolbe K, Irschick EU, Aman MJ, Gerken G, Färber L, Liehl E, Peschel C, Aulitzky WE, Huber C. Hladik F, et al. Ann Hematol. 1993 Aug;67(2):67-74. doi: 10.1007/BF01788129. Ann Hematol. 1993. PMID: 8347732

4

Effect of interleukin-3 pretreatment on granulocyte/macrophage colony-stimulating factor induced mobilization of circulating haemopoietic progenitor cells.

Geissler K, Peschel C, Niederwieser D, Goldschmitt J, Hladik F, Fritz A, Ohler L, Bettelheim P, Huber C, Lechner K, et al. Geissler K, et al. Among authors: hladik f. Br J Haematol. 1995 Oct;91(2):299-305. doi: 10.1111/j.1365-2141.1995.tb05293.x. Br J Haematol. 1995. PMID: 8547065

5

Biologic activity of low dosage IL-2 treatment in vivo. Molecular assessment of cytokine network interaction.

Hladik F, Tratkiewicz JA, Tilg H, Vogel W, Schwulera U, Krönke M, Aulitzky WE, Huber C. Hladik F, et al. J Immunol. 1994 Aug 15;153(4):1449-54. J Immunol. 1994. PMID: 8046224

6

Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells.

Hladik F, Desbien A, Lang J, Wang L, Ding Y, Holte S, Wilson A, Xu Y, Moerbe M, Schmechel S, McElrath MJ. Hladik F, et al. J Immunol. 2003 Sep 1;171(5):2671-83. doi: 10.4049/jimmunol.171.5.2671. J Immunol. 2003. PMID: 12928421

7

Recombinant HIV-1 glycoprotein 120 induces distinct types of delayed hypersensitivity in persons with or without pre-existing immunologic memory.

Hladik F, Bender S, Akridge RE, Hu YX, Galloway C, Francis D, McElrath MJ. Hladik F, et al. J Immunol. 2001 Mar 1;166(5):3580-8. doi: 10.4049/jimmunol.166.5.3580. J Immunol. 2001. PMID: 11207319 Clinical Trial.

8

Coexpression of CCR5 and IL-2 in human genital but not blood T cells: implications for the ontogeny of the CCR5+ Th1 phenotype.

Hladik F, Lentz G, Delpit E, McElroy A, McElrath MJ. Hladik F, et al. J Immunol. 1999 Aug 15;163(4):2306-13. J Immunol. 1999. PMID: 10438976

9

Setting the stage: host invasion by HIV.

Hladik F, McElrath MJ. Hladik F, et al. Nat Rev Immunol. 2008 Jun;8(6):447-57. doi: 10.1038/nri2302. Nat Rev Immunol. 2008. PMID: 18469831 Free PMC article. Review.

10

Immune defence against HIV-1 infection in HIV-1-exposed seronegative persons.

Schmechel SC, Russell N, Hladik F, Lang J, Wilson A, Ha R, Desbien A, McElrath MJ. Schmechel SC, et al. Among authors: hladik f. Immunol Lett. 2001 Nov 1;79(1-2):21-7. doi: 10.1016/s0165-2478(01)00262-0. Immunol Lett. 2001. PMID: 11595286

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters